Enzymotec (Enzymotec) COGS-to-Revenue : 0.30 (As of Sep. 2017)

View and export this data going back to 2013. Start your Free Trial

What is Enzymotec COGS-to-Revenue?

Enzymotec's Cost of Goods Sold for the three months ended in Sep. 2017 was $4.17 Mil. Its Revenue for the three months ended in Sep. 2017 was $13.67 Mil.

Enzymotec's COGS to Revenue for the three months ended in Sep. 2017 was 0.30.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Enzymotec's Gross Margin % for the three months ended in Sep. 2017 was 69.53%.

Enzymotec COGS-to-Revenue Historical Data

The historical data trend for Enzymotec's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzymotec COGS-to-Revenue Chart

Enzymotec Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

COGS-to-Revenue

Get a 7-Day Free Trial

0.52

0.49

0.39

0.37

Enzymotec Quarterly Data
	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
COGS-to-Revenue	Get a 7-Day Free Trial															0.34	0.54	0.30	0.50	0.30

Enzymotec COGS-to-Revenue Calculation

Enzymotec's COGS to Revenue for the fiscal year that ended in Dec. 2016 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	17.709	/	47.696
	=	0.37

Enzymotec's COGS to Revenue for the quarter that ended in Sep. 2017 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	4.166	/	13.672
	=	0.30

Enzymotec (NAS:ENZY) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Enzymotec's Gross Margin % for the three months ended in Sep. 2017 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	4.166 / 13.672
	=	69.53 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Enzymotec COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Enzymotec's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Enzymotec (Enzymotec) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enzymotec Ltd (NAS:ENZY) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.enzymotec.com

Enzymotec Ltd is nutritional and food ingredients company. It develops and manufactures nutritional ingredients and medical foods based on proprietary technologies. Its product portfolio includes Infat, K-Real, Enzy PS solutions, Vayacog, Vayarin and Vayaroll. The company has Nutrition and Vaya Pharma reportable segments. It derives majority of its revenues from Nutrition segment. The firm mainly operates in America, Europe, Australia, Asia, and Israel.

Enzymotec (Enzymotec) Headlines

From GuruFocus

Julian Robertson Adds to Multiple Positions in 3rd quarter

By Tiziano Frateschi Tiziano Frateschi • 12-20-2016

Julian Robertson Cuts Half of Stake in Paulson-Backed Company

By Holly LaFon Holly LaFon • 07-01-2016

Tiger Management Founder Julian Robertson Ups Stake in Enzymotec

By Kyle Ferguson Kyle Ferguson • 12-07-2015